Walleye Capital LLC - UNITY BIOTECHNOLOGY INC ownership

UNITY BIOTECHNOLOGY INC's ticker is UBX and the CUSIP is 91381U101. A total of 88 filers reported holding UNITY BIOTECHNOLOGY INC in Q4 2020. The put-call ratio across all filers is 1.05 and the average weighting 0.1%.

Quarter-by-quarter ownership
Walleye Capital LLC ownership history of UNITY BIOTECHNOLOGY INC
ValueSharesWeighting
Q1 2022$37,000
-53.2%
32,875
-39.5%
0.00%
-50.0%
Q4 2021$79,000
+107.9%
54,365
+331.2%
0.00%
+100.0%
Q3 2021$38,000
-82.2%
12,607
-72.5%
0.00%
-85.7%
Q2 2021$213,000
+34.0%
45,845
-0.5%
0.01%
-61.1%
Q3 2020$159,000
+29.3%
46,095
+170.4%
0.02%
+125.0%
Q4 2019$123,00017,0440.01%
Other shareholders
UNITY BIOTECHNOLOGY INC shareholders Q4 2020
NameSharesValueWeighting ↓
Founders Fund V Management, LLC 491,751$275,0002.22%
GSA CAPITAL PARTNERS LLP 639,937$361,0000.05%
PURA VIDA INVESTMENTS, LLC 359,089$202,0000.01%
Caption Management, LLC 725,000$409,0000.01%
Forefront Analytics, LLC 20,377$11,0000.01%
Johnson Midwest Financial, LLC 6,100$3,0000.00%
Virtu Financial LLC 62,640$35,0000.00%
Caption Management, LLC 225,000$127,0000.00%
SeaCrest Wealth Management, LLC 25,000$14,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 191,450$108,0000.00%
View complete list of UNITY BIOTECHNOLOGY INC shareholders